| 1WOF | A:; B: | CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR N1 |
| 2AMD | A:; B: | CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N9 |
| 2AMQ | A:; B: | CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N3 |
| 2D2D | A:; B: | CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR I2 |
| 2YY4 | | [entry was replaced by entry 5B6O without any SCOP domain information] |
| 3E91 | A:; B: | CRYSTAL STRUCTURE OF SARS-COV MPRO MUTANT IN P21 AT PH6.9 |
| 3EA7 | A:; B: | CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE TRIPLE MUTANT STI/A IN SPACE GROUP P21 |
| 3EA8 | A: | CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE TRIPLE MUTANT STI/A IN SPACE GROUP C2 |
| 3EA9 | A: | CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE QUADRUPLE MUTANT STIF/A WITH ONE MOLECULE IN ONE ASYMMETRIC UNIT |
| 3EAJ | A:; B: | CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE QUADRUPLE MUTANT STIF/A WITH TWO MOLECULES IN ONE ASYMMETRIC UNIT |
| 3M3T | A: | SARS-COV MAIN PROTEASE MONOMERIC ARG298ALA MUTANT WITH N-TERMINAL ADDITIONAL RESIDUES (GLY-SER) |
| 3M3V | A:; B: | SARS-COV MAIN PROTEASE TRIPLE MUTANT STI/A WITH TWO N-TERMINAL ADDITIONAL RESIDUE (GLY-SER) |
)
)